Cargando…

Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing

BACKGROUND: Biomarker-guided therapy in an experimental setting has been suggested to improve patient outcomes. However, trial-specific pre-screening tests are time and tissue consuming and complicate the personalised treatment of patients eligible for early-phase clinical trials. In this study the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pruis, Melinda A., Groenendijk, Floris H., Badloe, K. Sangeeta, van Puffelen, Andrea, Robbrecht, Debbie, Dinjens, Winand N. M., Sleijfer, Stefan, Dingemans, Anne-Marie C., von der Thüsen, Jan H., Roepman, Paul, Lolkema, Martijn P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381598/ https://www.ncbi.nlm.nih.gov/pubmed/35606463 http://dx.doi.org/10.1038/s41416-022-01841-3

Ejemplares similares

Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples
por: Mankor, Joanne M., et al.
Publicado: (2020)

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
por: Groenendijk, Floris H., et al.
Publicado: (2019)

MET immunochemistry: a reliable screening tool for MET exon 14 skipping mutations in non-small cell lung cancer?
por: Pruis, Melinda A., et al.
Publicado: (2020)

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation
por: Groenendijk, Floris H., et al.
Publicado: (2010)

Pan-cancer whole-genome analyses of metastatic solid tumours
por: Priestley, Peter, et al.
Publicado: (2019)

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer
por: Steendam, Christi M. J., et al.
Publicado: (2020)

Mitochondrial D310 mutation as clonal marker for solid tumors
por: Geurts-Giele, Willemina R. R., et al.
Publicado: (2015)

“If only I had”, patients’ experiences during early oncology trials
por: van Sasse van IJsselt, Maaike E. A., et al.
Publicado: (2023)

Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours
por: Lankheet, N A G, et al.
Publicado: (2014)

‘Personalised evidence’ for personalised healthcare: integration of a clinical librarian into mental health services – a feasibility study
por: Steele, Rachel, et al.
Publicado: (2014)

A Lung Cancer Patient with Dyspnea: Diagnostic Difficulties during the COVID-19 Pandemic
por: Pruis, Melinda A., et al.
Publicado: (2020)

Personalised exercise therapy and self-management support for people with multimorbidity: feasibility of the MOBILIZE intervention
por: Skou, Søren T., et al.
Publicado: (2023)

The effect of personalised versus non-personalised study invitations on recruitment within the ENGAGE feasibility trial: an embedded randomised controlled recruitment trial
por: Thiblin, Ella, et al.
Publicado: (2022)

A phase 1 open-label study to assess the relative bioavailability of TAK-931 tablets in reference to powder-in-capsule in patients with advanced solid tumors
por: Steeghs, Neeltje, et al.
Publicado: (2022)

TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian Cancer
por: Vitale, Silvia R., et al.
Publicado: (2020)

Personalised diet
Publicado: (2011)

Personalised Ecology
por: Gaston, Kevin J., et al.
Publicado: (2018)

Immunotherapy in Urothelial Cancer: Stop When Achieving a Response, Restart upon Disease Progression
por: Salhi, Youssra, et al.
Publicado: (2023)

Functional Polymorphisms Associated with Disease-Free Survival in Resected Carcinoma of the Esophagus
por: Boonstra, Jurjen J., et al.
Publicado: (2010)

Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer
por: Vitale, Silvia R., et al.
Publicado: (2021)

JOCR: Personalised Journal, Personalised Network and Clinical Decision Making (CDM)
por: Shyam, Ashok
Publicado: (2012)

In‐depth molecular analysis of combined and co‐primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma
por: Hermans, Bregtje C. M., et al.
Publicado: (2021)

Personalised nutrition and health
por: Ordovas, Jose M, et al.
Publicado: (2018)

Personalised Medicine in Europe
por: Andriukaitis, Vytenis
Publicado: (2017)

Whole genome sequencing in the study of disease and application in personalised medicine
por: Kumarasuriyar, A
Publicado: (2012)

Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Cancer: Outcomes of Cardio-Oncology Follow-Up
por: Pruis, Melinda A., et al.
Publicado: (2023)

Feasibility and acceptability of a personalised script-elicitation method for improving evening sleep hygiene habits
por: Mohideen, Anya, et al.
Publicado: (2023)

Mucinous carcinoid of the ovary: report of a case with metastasis in the contralateral ovary after ten years
por: Buis, Christien C.M, et al.
Publicado: (2010)

Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA
por: Bos, Manouk K., et al.
Publicado: (2020)

Other side of the coin for personalised medicine and healthcare: content analysis of ‘personalised’ practices in the literature
por: Cesuroglu, Tomris, et al.
Publicado: (2016)

“The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology”: letter to the Editor
por: Dinjens, Winand N. M., et al.
Publicado: (2020)

Implementing personalised care planning for older people with frailty: a process evaluation of the PROSPER feasibility trial
por: Kime, Nicky, et al.
Publicado: (2022)

Personalised Online Upper-Limb Physiotherapy for Stroke Survivors during the Inpatient Phase: A Feasibility Study
por: Alhusayni, Abdullah Ibrahim, et al.
Publicado: (2023)

Somatic mosaicism by a de novo MLH1 mutation as a cause of Lynch syndrome
por: Geurts‐Giele, Willemina R., et al.
Publicado: (2019)

Perspective: Towards Personalised Metabolic Coaching in Cancer
por: Van Soom *, T, et al.
Publicado: (2018)

Introduction to sessions on Personalising treatment
por: Dowsett, Mitch, et al.
Publicado: (2007)

The Promise and the Hype of ‘Personalised Medicine’
por: Maughan, Tim
Publicado: (2017)

Keeping the Person in Personalised Healthcare
por: Horgan, Denis
Publicado: (2017)

What is the promise of personalised nutrition?
por: Ferrario, Paola G., et al.
Publicado: (2021)

Dynamic consent and personalised medicine
por: Goncharov, Liza, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n05e9dt42trq28ivcps98gitj7